ACHC
Acadia Healthcare Company, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$28.13
−0.88%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4B | 3.3B | 3.2B | 2.9B | 2.6B |
| Cost of Revenue | 2.2B | 2.7B | 2.4B | 2.2B | 100.2M |
| Gross Profit | 1.2B | 583.4M | 712.0M | 682.6M | 2.5B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 682.7M | 195.5M | 189.7M | 176.0M | 1.6B |
| General & Admin Expense | 682.7M | 195.5M | 189.7M | 176.0M | 1.6B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 176.3M | — | — | — | 445.6M |
| Total Operating Expenses | 858.9M | 195.5M | 189.7M | 176.0M | 2.0B |
| Cost and Expenses | 3.0B | 2.9B | 2.6B | 2.4B | 2.1B |
| Operating Income (EBIT) | 338.8M | 388.0M | 522.3M | 506.6M | 467.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 151.1M | 138.9M | 116.4M | 82.1M | 69.8M |
| Net Interest Income | (151.1M) | (138.9M) | (116.4M) | (82.1M) | (69.8M) |
| Other Non-Op Income/Expense | (1.4B) | (1.5B) | (180.4M) | (532.0M) | (93.6M) |
| Non-Operating Income (excl Interest) | 1.2B | 1.3B | 64.0M | 449.8M | 23.8M |
| EBT (Pre-Tax Income) | (1.1B) | (1.1B) | 341.9M | (25.4M) | 374.1M |
| Income Tax Expense | 25.8M | 26.0M | 77.4M | (9.7M) | 94.1M |
| Bottom Line | |||||
| Net Income | (1.1B) | (1.1B) | 255.6M | (21.7M) | 273.1M |
| Earnings from Cont. Ops | (1.1B) | (1.1B) | 264.5M | (15.7M) | 280.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.1B) | (1.1B) | 255.6M | (21.7M) | 273.1M |
| Per Share | |||||
| Basic EPS | ($12.45) | ($12.16) | $2.79 | ($0.24) | $3.05 |
| Diluted EPS | ($12.45) | ($12.16) | $2.78 | ($0.24) | $2.98 |
| Revenue Per Share | $37.08 | $36.52 | $34.42 | $32.20 | $29.11 |
| Shares | |||||
| Basic Shares Outstanding | 90.8M | 90.7M | 91.6M | 90.9M | 89.7M |
| Diluted Shares Outstanding | 91.4M | 90.7M | 92.1M | 90.9M | 91.6M |
| Profitability Metrics | |||||
| EBITDA | (683.6M) | (737.8M) | 607.8M | 189.1M | 561.7M |
| D&A | 196.1M | 189.2M | 149.6M | 132.3M | 117.8M |
| EBIT | (879.6M) | (927.1M) | 458.2M | 56.8M | 443.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026